Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins. The company will be developing diagnostic tools to help patients and physicians detect disease in its earliest stages. Building on research from Dr. Hood, Dr. Jim Heath and other leading scientists, Integrated Diagnostics is creating powerful diagnostic tools and innovative biomarkers that will help define the coming transition to health care that is predictive, preventive, personalized and participatory.
"Just as the DNA sequencer allowed us to decode the human genome, the technology behind Integrated Diagnostics will allow us unprecedented insight into preventing and treating diseases like cancer, diabetes and Alzheimer's by analyzing the proteins that appear in their earliest stages," said Dr. Hood, current president of The Institute for Systems Biology (ISB); and inventor of the DNA sequencer, which played a crucial role in the mapping of the human genome. "I have had the good fortune to found several successful biotechnology companies. I believe Integrated Diagnostics will prove to be among the most significant. By taking a systems approach to monitoring an individual's health we will be able to provide physicians and patients an early warning system for preventing and treating diseases."